Patent EP0353450A1 successfully refreshed from Google Patents.
EP0353450A1
Expired / Lapsed
EP
⏱️ 0.0 years remaining
Macrocyclic bifunctional chelants, complexes thereof and their antibody conjugates
Assignee: Dow Chemical Co
•
Filing: 1989-06-23
•
Granted: —
•
Expires: 2009-06-23
Abstract
Abstract A group of functionalized polyaminocarboxylate chelants that form complexes with rare earth-type metal ions are disclosed. The complexes can be covalently attached to an antibody or antibody fragment and used for therapeutic and/or diagnostic purposes.
Inventors
- 👤 Roberta C. Cheng
- 👤 William A. Fordyce
- 👤 William F. Goeckeler
- 👤 William F. Kruper, Jr.
- 👤 Sharon Baughman
- 👤 Joseph R. Garlich
- 👤 Garry Kiefer
- 👤 Kenneth Mcmillan
- 👤 Jaime J. Simon
- 👤 David A. Wilson
- 👤 Richard Keith Frank
Bibliographic Details
Application Number
—
Jurisdiction
EP
Data Source
google_patents
Last Synchronized
2026-11-08 08:10
CPC Classifications
C; C07; C07D; C07D257/00; C07D257/02; A; A61; A61K; A61K31/00; A61K31/33; A61K31/395; A61K51/00; A61K51/02; A61K51/04; A61K51/0474; A61K51/0482; A61K51/08; A61K51/10; A61K51/1045; A61K51/1084; A61K51/109; A61P; A61P35/00; A61K2121/00; A61K2123/00
Claims Analysis
Total Claims: 116
Claim 1
Independent Claim
288 words
A compound of the formula wherein: each Q is independently hydrogen or (CHR⁵) p CO₂R; Q¹ is hydrogen or (CHR⁵) w CO₂R; each R independently is hydrogen, benzyl or C₁-C₄ alkyl; with the proviso that at least two of the sum of Q and Q¹ must be other than hydrogen; each R⁵ independently is hydrogen or C₁-C₄ alkyl; X and Y are each independently hydrogen or may be taken with an adjacent X and Y to form an additional carbon-carbon bond; n is 0 or 1; m is an integer from 0 to 10 inclusive; p = 1 or 2; r = 0 or 1; w = 0 or 1; with the proviso that n is only 1 when X and/or Y form an additional carbon-carbon bond, and the sum of r and w is 0 or 1; L is a linker/spacer group covalently bonded to, and replaces one hydrogen atom of one of the carbon atoms to which it is joined, said linker/spacer group being represented by the formula wherein: s is an integer of 0 or 1; t is an integer of 0 to 20 inclusive; R¹ is an electrophilic or nucleophilic moiety which allows for covalent attachment to an antibody or fragment thereof, or a synthetic linker which can be attached to an antibody or fragment thereof, or a precursor thereof; and Cyc represents a cyclic aliphatic moiety, aromatic moiety, aliphatic heterocyclic moiety, or aromatic heterocyclic moiety, each of said moieties optionally substituted with one or more groups which do not interfere with binding to an antibody or antibody fragment; with the proviso that when s, t, m, r and n are 0, then R¹ is other than carboxyl; or a pharmaceutically acceptable salt thereof,.
Claim 2
Dependent Claim
288 words
A compound of the formula wherein: each Q is independently hydrogen or (CHR⁵) p CO₂R; Q¹ is hydrogen or (CHR⁵) w CO₂R; each R independently is hydrogen, benzyl or C₁-C₄ alkyl; with the proviso that at least two of the sum of Q and Q¹ must be other than hydrogen; each R⁵ independently is hydrogen or C₁-C₄ alkyl; X and Y are each independently hydrogen or may be taken with an adjacent X and Y to form an additional carbon-carbon bond; n is 0 or 1; m is an integer from 0 to 10 inclusive; p = 1 or 2; r = 0 or 1; w = 0 or 1; with the proviso that n is only 1 when X and/or Y form an additional carbon-carbon bond, and the sum of r and w is 0 or 1; L is a linker/spacer group covalently bonded to, and replaces one hydrogen atom of one of the carbon atoms to which it is joined, said linker/spacer group being represented by the formula wherein: s is an integer of 0 or 1; t is an integer of 0 to 20 inclusive; R¹ is an electrophilic or nucleophilic moiety which allows for covalent attachment to an antibody or fragment thereof, or a synthetic linker which can be attached to an antibody or fragment thereof, or a precursor thereof; and Cyc represents a cyclic aliphatic moiety, aromatic moiety, aliphatic heterocyclic moiety, or aromatic heterocyclic moiety, each of said moieties optionally substituted with one or more groups which do not interfere with binding to an antibody or antibody fragment; with the proviso that when s, t, m, r and n are 0, then R¹ is other than carboxyl; or a pharmaceutically acceptable salt thereof,.
Claim 3
Dependent Claim
27 words
A compound of Claim 1 wherein the pharmaceutically acceptable salt is selected from the group consisting of potassium, sodium, lithium, ammonium, calcium, magnesium, and hydrogen chloride adducts.
Claim 4
Dependent Claim
12 words
A compound of Claim 1 wherein R and R⁵ are both hydrogen.
Claim 5
Dependent Claim
16 words
A compound of Claim 1 wherein R is hydrogen, R⁵ is methyl and w is 0.
Claim 6
Dependent Claim
18 words
A compound of Claim 1 wherein n and r are both 0 and m is 0 through 5.
Claim 7
Dependent Claim
96 words
A compound of the formula: wherein: X, Y, Q, Q¹, n, m, and r are defined as in Claim 1; R² is selected from the group consisting of hydrogen, nitro, amino, isothiocyanato, semicarbazido, thiosemicarbazido, maleimido, bromoacetamido and carboxyl; R³ is selected from the group consisting of C₁-C₄ alkoxy, -OCH₂CO₂H, hydroxy and hydrogen; R⁴ is selected from the group consisting of hydrogen, nitro, amino, isothiocyanato, semicarbazido, thiosemicarbazido, maleimido, bromoacetamido and carboxyl; with the proviso that R² and R⁴ cannot both be hydrogen but one of R² and R⁴ must be hydrogen; or a pharmaceutically acceptable salt thereof.
Claim 8
Dependent Claim
11 words
A compound of Claim 6 wherein R³ and R⁴ are hydrogen.
Claim 9
Dependent Claim
132 words
A compound of Claim 6 having the formula wherein: each Q is independently hydrogen or CHR⁵CO₂R; each R independently is hydrogen, benzyl or C₁-C₄ alkyl; with the proviso that at least two of Q must be other than hydrogen; m is an integer from 0 to 5 inclusive; R² is selected from the group consisting of hydrogen, nitro, amino, isothiocyanato, semicarbazido, thiosemicarbazido, maleimido, bromoacetamido and carboxyl; R³ is selected from the group consisting of C₁-C₄ alkoxy, -OCH₂CO₂H, hydroxy and hydrogen; R⁴ is selected from the group consisting of hydrogen, nitro, amino, isothiocyanato, semicarbazido, thiosemicarbazido, maleimido, bromoacetamido and carboxyl; each R⁵ independently is hydrogen or C₁-C₄ alkyl; with the proviso that R² and R⁴ cannot both be hydrogen but one of R² and R⁴ must be hydrogen; or a pharmaceutically acceptable salt thereof.
Claim 10
Dependent Claim
72 words
A compound of Claim 8 having the formula wherein: each Q is independently hydrogen or CHR⁵CO₂R; each R independently is hydrogen, benzyl or C₁-C₄ alkyl; with the proviso that at least two of Q must be other than hydrogen; m is an integer from 0 to 5 inclusive; R² is selected from the group consisting of nitro, amino, isothiocyanato, and semicarbazido, thiosemicarbazido, maleimido, bromoacetamido and carboxyl; or a pharmaceutically acceptable salt thereof.
Claim 11
Dependent Claim
14 words
The compound of Claim 9 which is 1-[2-(4-aminophenyl)ethyl]-1 ,4,7, 10-tetraazacyclododecane-4,7,10-triacetic acid, 4,7, 10-trimethyl ester.
Claim 12
Dependent Claim
11 words
The compound of Claim 9 which is 1-[2-(4-aminophenyl)ethyl]-1,4,7,10-tetraazacyclododecane-4,7,10-triacetic acid, hydrochloride salt.
Claim 13
Dependent Claim
10 words
The compound of Claim 9 which is 1-[2-(4-isothiocyanatophenyl)ethyl]-1 ,4,7,10-tetraazacyclododecane-4,7,10-triacetic acid.
Claim 14
Dependent Claim
11 words
The compound of Claim 9 which is 1-(4-aminobenzyl)-1,4,7,10-tetraazacyclododecane-4,7,10-triacetic acid, hydrochloride salt.
Claim 15
Dependent Claim
92 words
A compound of Claim 8 having the formula wherein: each Q is independently hydrogen or CHR⁵CO₂R; each R independently is hydrogen, benzyl or C₁-C₄ alkyl; with the proviso that at least two of Q must be other than hydrogen; m is an integer from 0 to 5 inclusive; R³ is selected from the group consisting of C₁-C₄ alkoxy, -OCH₂CO₂H and hydroxy; R⁴ is selected from the group consisting of nitro, amino, isothiocyanato, semicarbazido, thiosemicarbazido, maleimido, bromoacetamido and carboxyl; each R⁵ independently is hydrogen or C₁-C₄ alkyl; or a pharmaceutically acceptable salt thereof.
Claim 16
Dependent Claim
9 words
The compound of Claim 14 which is 1-(2-methoxy-5-aminobenzyl)-1,4,7,10-tetraazacyclododecane-4,7,10-triacetic acid.
Claim 17
Dependent Claim
9 words
The compound of Claim 14 which is 1-(2-hydroxy-5-aminobenzyl)-1,4,7,10-tetraazacyclododecane-4,7,10-triacetic acid.
Claim 18
Dependent Claim
155 words
A compound of Claim 6 having the formula wherein: each Q is independently hydrogen or CHR⁵CO₂R; Q¹ is hydrogen or (CHR⁵) w CO₂R; each R independently is hydrogen, benzyl or C₁-C₄ alkyl; with the proviso that at least two of the sum of Q and Q¹ must be other than hydrogen and one of Q is hydrogen; m is an integer from 0 to 5 inclusive; w is 0 or 1; R² is selected from the group consisting of hydrogen, nitro, amino, isothiocyanato, semicarbazido, thiosemicarbazido, maleimido, bromoacetamido and carboxyl; R³ is selected from the group consisting of C₁-C₄ alkoxy, -OCH₂CO₂H, hydroxy and hydrogen; R⁴ is selected from the group consisting of hydrogen, nitro, amino, isothiocyanato, semicarbazido, thiosemicarbazido, maleimido, bromoacetamido and carboxyl; each R⁵ independently is hydrogen or C₁-C₄ alkyl; with the proviso that R² and R⁴ cannot both be hydrogen but one of R² and R⁴ must be hydrogen; or a pharmaceutically acceptable salt thereof.
Claim 19
Dependent Claim
14 words
The compound of Claim 17 wherein R is hydrogen and R⁵ is C₁₋₄ alkyl.
Claim 20
Dependent Claim
131 words
A compound of Claim 6 having the formula wherein: each Q is independently hydrogen or CHR⁵CO₂R; each R independently is hydrogen, benzyl or C₁-C₄ alkyl; with the proviso that at least one Q must be other than hydrogen; m is an integer from 0 to 5 inclusive; R² is selected from the group consisting of hydrogen, nitro, amino, isothiocyanato, semicarbazido, thiosemicarbazido, maleimido, bromoacetamido and carboxyl; R³ is selected from the group consisting of C₁-C₄ alkoxy, -OCH₂CO₂H, hydroxy and hydrogen; R⁴ is selected from the group consisting of hydrogen, nitro, amino, isothiocyanato, semicarbazido, thiosemicarbazido, maleimido, bromoacetamido and carboxyl; each R⁵ independently is hydrogen or C₁-C₄ alkyl; with the proviso that R² and R⁴ cannot both be hydrogen but one of R² and R⁴ must be hydrogen; or a pharmaceutically acceptable salt thereof.
Claim 21
Dependent Claim
78 words
A compound of Claim 19 having the formula wherein: each Q is independently hydrogen or CHR⁵CO₂R; each R independently is hydrogen, benzyl or C₁-C₄ alkyl; with the proviso that at least one Q must be other than hydrogen; m is an integer from 0 to 5 inclusive; R² is selected from the group consisting of nitro, amino, isothiocyanato, semicarbazido, thiosemicarbazido, maleimido, bromoacetamido and carboxyl; each R⁵ independently is H or C₁-C₄ alkyl; or a pharmaceutically acceptable salt thereof.
Claim 22
Dependent Claim
12 words
The compound of Claim 20 which is α-[2-(4-aminophenyl)ethyl]-1,4,7,10-tetraazacyclododecane-1-(R,S)-acetic 4,7,10-tris-(R-methylacetic) acid, 1-isopropyl-4,7,10-trimethyl ester.
Claim 23
Dependent Claim
10 words
The compound of Claim 20 which is α-[2-(4-aminophenyl)ethyl]-1,4,7,10-tetraazacyclododecane-1-(R,S)-acetic 4,7,10-tris-(R-methylacetic) acid.
Claim 24
Dependent Claim
9 words
The compound of Claim 20 which is α-[2-(4-isothiocyanatophenyl)ethyl]-1,4,7,10-tetraazacyclododecane-1-(R,S)-acetic-4,7,10-tris-(R-methylacetic) acid.
Claim 25
Dependent Claim
13 words
The compound of Claim 20 which is α-[2-(4-aminophenyl)ethyl]-1,4,7,10-tetraazacyclododecane-1,4,10-triacetic acid, mixed ammonium, potassium salt.
Claim 26
Dependent Claim
9 words
The compound of Claim 20 which is α-(4-aminophenyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid.
Claim 27
Dependent Claim
9 words
The compound of Claim 20 which is α-(4-aminophenyl)-1,4,7,10-tetraazacyclododecane-1,4,10-triacetic acid.
Claim 28
Dependent Claim
9 words
The compound of Claim 20 which is α-(4-aminophenyl)-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid.
Claim 29
Dependent Claim
9 words
The compound of Claim 20 which is α-(4-isothiocyanatophenyl)-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid.
Claim 30
Dependent Claim
11 words
The compound of Claim 20 which is α-[2-(4-nitrophenyl)ethyl]-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid, 1,4,7,10-tetramethyl ester.
Claim 31
Dependent Claim
11 words
The compound of Claim 20 which is α-[2-(4-aminophenyl)ethyl]-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid, 1,4,7,10-tetramethyl ester.
Claim 32
Dependent Claim
9 words
The compound of Claim 20 which is α-[2-(4-aminophenyl)ethyl]-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid.
Claim 33
Dependent Claim
9 words
The compound of Claim 20 which is α-[2-(4-isothiocyanatophenyl)ethyl]-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid.
Claim 34
Dependent Claim
92 words
A compound of Claim 6 having the formula wherein: each Q is independently hydrogen or CHR⁵CO₂R; each R independently is hydrogen, benzyl or C₁-C₄ alkyl; with the proviso that at least one Q must be other than hydrogen; m is an integer from 0 to 5 inclusive; R³ is selected from the group consisting of C₁-C₄ alkoxy, -OCH₂CO₂H, hydroxy and hydrogen; R⁴ is selected from the group consisting of nitro, amino, isothiocyanato, semicarbazido, thiosemicarbazido, maleimido, bromoacetamido and carboxyl; each R⁵ independently is hydrogen or C₁-C₄ alkyl; or a pharmaceutically acceptable salt thereof.
Claim 35
Dependent Claim
9 words
The compound of Claim 32 which is α-(2-methoxy-5-nitrophenyl)-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid.
Claim 36
Dependent Claim
11 words
The compound of Claim 32 which is α-(2-methoxy-5-aminophenyl)-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid, tetraamonium salt.
Claim 37
Dependent Claim
11 words
The compound of Claim 32 which is α-(2-methoxy-5-isothiocynatophenyl)-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid, tetraamonium salt.
Claim 38
Dependent Claim
322 words
A complex which comprises a compound of the formula wherein: each Q is independently hydrogen or (CHR⁵) p CO₂R; Q¹ is hydrogen or (CHR⁵) w CO₂R; each R independently is hydrogen, benzyl or C₁-C₄ alkyl; with the proviso that at least two of the sum of Q and Q¹ must be other than hydrogen; each R⁵ independently is hydrogen or C₁-C₄ alkyl; X and Y are each independently hydrogen or may be taken with an adjacent X and Y to form an additional carbon-carbon bond; n is 0 or 1; m is an integer from 0 to 10 inclusive; p = 1 or 2; r = 0 or 1; w = 0 or 1; with the proviso that n is only 1 when X and/or Y form an additional carbon-carbon bond, and the sum of r and w is 0 or 1; L is a linker/spacer group covalently bonded to, and replaces one hydrogen atom of one of the carbon atoms to which it is joined, said linker/spacer group being represented by the formula wherein: s is an integer of 0 or 1; t is an integer of 0 to 20 inclusive; R¹ is an electrophilic or nucleophilic moiety which allows for covalent attachment to an antibody or fragment thereof, or a synthetic linker which can be attached to an antibody or fragment thereof, or precursor thereof; and Cyc represents a cyclic aliphatic moiety, aromatic moiety, aliphatic heterocyclic moiety, or aromatic heterocyclic moiety, each of said moieties optionally substituted with one or more groups which do not interfere with binding to an antibody or antibody fragment; with the proviso that when s, t, m, r and n are 0, then R¹ is other than carboxyl; or a pharmaceutically acceptable salt thereof; complexed with an ion of a metal selected from the group consisting of La, Ce, Pr, Nd, Pm, Sm, Eu, Gd, Tb, Dy, Ho, Er, Tm, Yb, Lu, Y and Sc.
Claim 39
Dependent Claim
322 words
A complex which comprises a compound of the formula wherein: each Q is independently hydrogen or (CHR⁵) p CO₂R; Q¹ is hydrogen or (CHR⁵) w CO₂R; each R independently is hydrogen, benzyl or C₁-C₄ alkyl; with the proviso that at least two of the sum of Q and Q¹ must be other than hydrogen; each R⁵ independently is hydrogen or C₁-C₄ alkyl; X and Y are each independently hydrogen or may be taken with an adjacent X and Y to form an additional carbon-carbon bond; n is 0 or 1; m is an integer from 0 to 10 inclusive; p = 1 or 2; r = 0 or 1; w = 0 or 1; with the proviso that n is only 1 when X and/or Y form an additional carbon-carbon bond, and the sum of r and w is 0 or 1; L is a linker/spacer group covalently bonded to, and replaces one hydrogen atom of one of the carbon atoms to which it is joined, said linker/spacer group being represented by the formula wherein: s is an integer of 0 or 1; t is an integer of 0 to 20 inclusive; R¹ is an electrophilic or nucleophilic moiety which allows for covalent attachment to an antibody or fragment thereof, or a synthetic linker which can be attached to an antibody or fragment thereof, or precursor thereof; and Cyc represents a cyclic aliphatic moiety, aromatic moiety, aliphatic heterocyclic moiety, or aromatic heterocyclic moiety, each of said moieties optionally substituted with one or more groups which do not interfere with binding to an antibody or antibody fragment; with the proviso that when s, t, m, r and n are 0, then R¹ is other than carboxyl; or a pharmaceutically acceptable salt thereof; complexed with an ion of a metal selected from the group consisting of La, Ce, Pr, Nd, Pm, Sm, Eu, Gd, Tb, Dy, Ho, Er, Tm, Yb, Lu, Y and Sc.
Claim 40
Dependent Claim
14 words
A complex of Claim 36 wherein the metal ion is Sm, Lu or Y.
Claim 41
Dependent Claim
21 words
A complex of Claim 36 wherein the metal ion is ¹⁵³Sm, ¹⁶⁶Ho, ⁹⁰Y, ¹⁴⁹Pm, ¹⁵⁹Gd, ¹⁴⁰La, ¹⁷⁷Lu, ¹⁷⁵Yb, ⁴⁷Sc, or ¹⁴²Pr.
Claim 42
Dependent Claim
14 words
A complex of Claim 38 wherein the metal ion is ¹⁵³Sm, ¹⁷⁷Lu or ⁹⁰Y.
Claim 43
Dependent Claim
22 words
A complex of any one of Claims 36 through 39 wherein the metal ion is complexed with the compound of Claim 6.
Claim 44
Dependent Claim
22 words
A complex of any one of Claims 36 through 39 wherein the metal ion is complexed with the compound of Claim 8.
Claim 45
Dependent Claim
22 words
A complex of any one of Claims 36 through 39 wherein the metal ion is complexed with the compound of Claim 9.
Claim 46
Dependent Claim
22 words
A complex of any one of Claims 36 through 39 wherein the metal ion is complexed with the compound of Claim 14.
Claim 47
Dependent Claim
22 words
A complex of any one of Claims 36 through 39 wherein the metal ion is complexed with the compound of Claim 17.
Claim 48
Dependent Claim
22 words
A complex of any one of Claims 36 through 39 wherein the metal ion is complexed with the compound of Claim 19.
Claim 49
Dependent Claim
22 words
A complex of any one of Claims 36 through 39 wherein the metal ion is complexed with the compound of Claim 20.
Claim 50
Dependent Claim
22 words
A complex of any one of Claims 36 through 39 wherein the metal ion is complexed with the compound of Claim 32.
Claim 51
Dependent Claim
17 words
A complex of Claim 38 wherein the metal ion is complexed with the compound of Claim 27.
Claim 52
Dependent Claim
18 words
A complex of Claim 48 wherein the metal ion is ¹⁵³Sm complexed with the compound of Claim 27.
Claim 53
Dependent Claim
18 words
A complex of Claim 48 wherein the metal ion is ⁹⁰Y complexed with the compound of Claim 27.
Claim 54
Dependent Claim
17 words
A complex of Claim 38 wherein the metal ion is complexed with the compound of Claim 28.
Claim 55
Dependent Claim
18 words
A complex of Claim 51 wherein the metal ion is ¹⁵³Sm complexed with the compound of Claim 28.
Claim 56
Dependent Claim
17 words
A complex of Claim 38 wherein the metal ion is complexed with the compound of Claim 31.
Claim 57
Dependent Claim
18 words
A complex of Claim 53 wherein the metal ion is ¹⁵³Sm complexed with the compound of Claim 31.
Claim 58
Dependent Claim
18 words
A complex of Claim 53 wherein the metal ion is ⁹⁰Y complexed with the compound of Claim 31.
Claim 59
Dependent Claim
18 words
A complex of Claim 53 wherein the metal ion is ¹⁷⁷Lu complexed with the compound of Claim 31.
Claim 60
Dependent Claim
17 words
A complex of Claim 38 wherein the metal ion is complexed with the compound of Claim 32.
Claim 61
Dependent Claim
18 words
A complex of Claim 57 wherein the metal ion is ¹⁵³Sm complexed with the compound of Claim 32.
Claim 62
Dependent Claim
18 words
A complex of Claim 57 wherein the metal ion is ⁹⁰Y complexed with the compound of Claim 32.
Claim 63
Dependent Claim
18 words
A complex of Claim 57 wherein the metal ion is ¹⁷⁷Lu complexed with the compound of Claim 32.
Claim 64
Dependent Claim
17 words
A complex of Claim 38 wherein the metal ion is complexed with the compound of Claim 11.
Claim 65
Dependent Claim
18 words
A complex of Claim 61 wherein the metal ion is ¹⁵³Sm complexed with the compound of Claim 11.
Claim 66
Dependent Claim
17 words
A complex of Claim 38 wherein the metal ion is complexed with the compound of Claim 12.
Claim 67
Dependent Claim
18 words
A complex of Claim 63 wherein the metal ion is ¹⁵³Sm complexed with the compound of Claim 12.
Claim 68
Dependent Claim
17 words
A complex of Claim 38 wherein the metal ion is complexed with the compound of Claim 34.
Claim 69
Dependent Claim
18 words
A complex of Claim 65 wherein the metal ion is ¹⁵³Sm complexed with the compound of Claim 34.
Claim 70
Dependent Claim
17 words
A complex of Claim 38 wherein the metal ion is complexed with the compound of Claim 35.
Claim 71
Dependent Claim
18 words
A complex of Claim 67 wherein the metal ion is ¹⁵³Sm complexed with the compound of Claim 35.
Claim 72
Dependent Claim
17 words
A complex of Claim 38 wherein the metal ion is complexed with the compound of Claim 22.
Claim 73
Dependent Claim
18 words
A complex of Claim 69 wherein the metal ion is ¹⁵³Sm complexed with the compound of Claim 22.
Claim 74
Dependent Claim
18 words
A complex of Claim 69 wherein the metal ion is ⁹⁰Y complexed with the compound of Claim 22.
Claim 75
Dependent Claim
18 words
A complex of Claim 69 wherein the metal ion is ¹⁷⁷Lu complexed with the compound of Claim 22.
Claim 76
Dependent Claim
17 words
A complex of Claim 38 wherein the metal ion is complexed with the compound of Claim 23.
Claim 77
Dependent Claim
18 words
A complex of Claim 73 wherein the metal ion is ¹⁵³Sm complexed with the compound of Claim 23.
Claim 78
Dependent Claim
18 words
A complex of Claim 73 wherein the metal ion is ⁹⁰Y complexed with the compound of Claim 23.
Claim 79
Dependent Claim
17 words
A complex of Claim 73 wherein the metal ion ¹⁷⁷Lu complexed with the compound of Claim 23.
Claim 80
Dependent Claim
330 words
A conjugate comprising a compound of the formula wherein: each Q is independently hydrogen or (CHR⁵) p CO₂R; Q¹ is hydrogen or (CHR⁵) w CO₂R; each R independently is hydrogen, benzyl or C₁-C₄ alkyl; with the proviso that at least two of the sum of Q and Q¹ must be other than hydrogen; each R⁵ independently is hydrogen or C₁-C₄ alkyl; X and Y are each independently hydrogen or may be taken with an adjacent X and Y to form an additional carbon-carbon bond; n is 0 or 1; m is an integer from 0 to 10 inclusive; p = 1 or 2; r = 0 or 1; w = 0 or 1; with the proviso that n is only 1 when X and/or Y form an additional carbon-carbon bond, and the sum of r and w is 0 or 1;; L is a linker/spacer group covalently bonded to, and replaces one hydrogen atom of one of the carbon atoms to which it is joined, said linker/spacer group being represented by the formula wherein: s is an integer of 0 or 1; t is an integer of 0 to 20 inclusive; R¹ is an electrophilic or nucleophilic moiety which allows for covalent attachment to an antibody or fragment thereof, or a synthetic linker which can be attached to an antibody or fragment thereof, or precursor thereof; and Cyc represents a cyclic aliphatic moiety, aromatic moiety, aliphatic heterocyclic moiety, or aromatic heterocyclic moiety, each of said moieties optionally substituted with one or more groups which do not interfere with binding to an antibody or antibody fragment; with the proviso that when s, t, m, r and n are 0, then R¹ is other than carboxyl; or a pharmaceutically acceptable salt thereof; complexed with an ion of a metal selected from the group consisting of La, Ce, Pr, Nd, Pm, Sm, Eu, Gd, Tb, Dy, Ho, Er, Tm, Yb, Lu, Y and Sc; and covalently attached to an antibody or antibody fragment.
Claim 81
Dependent Claim
330 words
A conjugate comprising a compound of the formula wherein: each Q is independently hydrogen or (CHR⁵) p CO₂R; Q¹ is hydrogen or (CHR⁵) w CO₂R; each R independently is hydrogen, benzyl or C₁-C₄ alkyl; with the proviso that at least two of the sum of Q and Q¹ must be other than hydrogen; each R⁵ independently is hydrogen or C₁-C₄ alkyl; X and Y are each independently hydrogen or may be taken with an adjacent X and Y to form an additional carbon-carbon bond; n is 0 or 1; m is an integer from 0 to 10 inclusive; p = 1 or 2; r = 0 or 1; w = 0 or 1; with the proviso that n is only 1 when X and/or Y form an additional carbon-carbon bond, and the sum of r and w is 0 or 1;; L is a linker/spacer group covalently bonded to, and replaces one hydrogen atom of one of the carbon atoms to which it is joined, said linker/spacer group being represented by the formula wherein: s is an integer of 0 or 1; t is an integer of 0 to 20 inclusive; R¹ is an electrophilic or nucleophilic moiety which allows for covalent attachment to an antibody or fragment thereof, or a synthetic linker which can be attached to an antibody or fragment thereof, or precursor thereof; and Cyc represents a cyclic aliphatic moiety, aromatic moiety, aliphatic heterocyclic moiety, or aromatic heterocyclic moiety, each of said moieties optionally substituted with one or more groups which do not interfere with binding to an antibody or antibody fragment; with the proviso that when s, t, m, r and n are 0, then R¹ is other than carboxyl; or a pharmaceutically acceptable salt thereof; complexed with an ion of a metal selected from the group consisting of La, Ce, Pr, Nd, Pm, Sm, Eu, Gd, Tb, Dy, Ho, Er, Tm, Yb, Lu, Y and Sc; and covalently attached to an antibody or antibody fragment.
Claim 82
Dependent Claim
20 words
The conjugate of Claim 77 wherein the metal is ¹⁵³Sm, ¹⁶⁶Ho, ⁹⁰Y, ¹⁴⁹Pm, ¹⁵⁹Gd, ¹⁴⁰La, ¹⁷⁷Lu, ¹⁷⁵Yb, ⁴⁷Sc or ¹⁴²Pr.
Claim 83
Dependent Claim
13 words
The conjugate of Claim 78 wherein the metal is ¹⁵³Sm, ⁹⁰Y or ¹⁷⁷Lu.
Claim 84
Dependent Claim
23 words
A conjugate of any one of Claims 77 through 79 wherein the antibody or antibody fragment is a monoclonal antibody or fragment thereof.
Claim 85
Dependent Claim
20 words
A conjugate of Claim 80 wherein the antibody or antibody fragment is CC-49, CC-49 F(ab′)₂, CC-83, CC-83 F(ab′)₂ or B72.3.
Claim 86
Dependent Claim
19 words
A conjugate of any one of Claims 77 through 81 wherein the compound is as defined in Claim 6.
Claim 87
Dependent Claim
19 words
A conjugate of any one of Claims 77 through 81 wherein the compound is as defined in Claim 8.
Claim 88
Dependent Claim
19 words
A conjugate of any one of Claims 77 through 81 wherein the compound is as defined in Claim 9.
Claim 89
Dependent Claim
19 words
A conjugate of any one of Claims 77 through 81 wherein the compound is as defined in Claim 14.
Claim 90
Dependent Claim
19 words
A conjugate of any one of Claims 77 through 81 wherein the compound is as defined in Claim 17.
Claim 91
Dependent Claim
19 words
A conjugate of any one of Claims 77 through 81 wherein the compound is as defined in Claim 19.
Claim 92
Dependent Claim
19 words
A conjugate of any one of Claims 77 through 81 wherein the compound is as defined in Claim 20.
Claim 93
Dependent Claim
19 words
A conjugate of any one of Claims 77 through 81 wherein the compound is as defined in Claim 32.
Claim 94
Dependent Claim
23 words
A conjugate of any one of Claims 78 through 81 wherein the metal ion is ¹⁵³Sm complexed with the compound of Claim 28.
Claim 95
Dependent Claim
23 words
A conjugate of any one of Claims 78 through 81 wherein the metal ion is ¹⁵³Sm complexed with the compound of Claim 32.
Claim 96
Dependent Claim
23 words
A conjugate of any one of Claims 78 through 81 wherein the metal ion is ⁹⁰Y complexed with the compound of Claim 32.
Claim 97
Dependent Claim
23 words
A conjugate of any one of Claims 78 through 81 wherein the metal ion is ¹⁷⁷Lu complexed with the compound of Claim 32.
Claim 98
Dependent Claim
23 words
A conjugate of any one of Claims 78 through 81 wherein the metal ion is ¹⁵³Sm complexed with the compound of Claim 35.
Claim 99
Dependent Claim
23 words
A conjugate of any one of Claims 78 through 81 wherein the metal ion is ¹⁵³Sm complexed with the compound of Claim 23.
Claim 100
Dependent Claim
23 words
A conjugate of any one of Claims 78 through 81 wherein the metal ion is ⁹⁰Y complexed with the compound of Claim 23.
Claim 101
Dependent Claim
23 words
A conjugate of any one of Claims 78 through 81 wherein the metal ion is ¹⁷⁷Lu complexed with the compound of Claim 23.
Claim 102
Dependent Claim
297 words
A conjugate comprising a compound of the formula wherein: each Q is independently hydrogen or (CHR⁵) p CO₂R; Q¹ is hydrogen or (CHR⁵) w CO₂R; each R independently is hydrogen, benzyl or C₁-C₄ alkyl; with the proviso that at least two of the sum of Q and Q¹ must be other than hydrogen; each R⁵ independently is hydrogen or C₁-C₄ alkyl; X and Y are each independently hydrogen or may be taken with an adjacent X and Y to form an additional carbon-carbon bond; n is 0 or 1; m is an integer from 0 to 10 inclusive; p = 1 or 2; r = 0 or 1; w = 0 or 1; with the proviso that n is only 1 when X and/or Y form an additional carbon-carbon bond, and the sum of r and w is 0 or 1;; L is a linker/spacer group covalently bonded to, and replaces one hydrogen atom of one of the carbon atoms to which it is joined, said linker/spacer group being represented by the formula wherein: s is an integer of 0 or 1; t is an integer of 0 to 20 inclusive; R¹ is an electrophilic or nucleophilic moiety which allows for covalent attachment to an antibody or fragment thereof, or a synthetic linker which can be attached to an antibody or fragment thereof, or precursor thereof; and Cyc represents a cyclic aliphatic moiety, aromatic moiety, aliphatic heterocyclic moiety, or aromatic heterocyclic moiety, each of said moieties optionally substituted with one or more groups which do not interfere with binding to an antibody or antibody fragment; with the proviso that when s, t, m, r and n are 0, then R¹ other than carboxyl; or a pharmaceutically acceptable salt thereof; covalently attached to an antibody or antibody fragment.
Claim 103
Dependent Claim
297 words
A conjugate comprising a compound of the formula wherein: each Q is independently hydrogen or (CHR⁵) p CO₂R; Q¹ is hydrogen or (CHR⁵) w CO₂R; each R independently is hydrogen, benzyl or C₁-C₄ alkyl; with the proviso that at least two of the sum of Q and Q¹ must be other than hydrogen; each R⁵ independently is hydrogen or C₁-C₄ alkyl; X and Y are each independently hydrogen or may be taken with an adjacent X and Y to form an additional carbon-carbon bond; n is 0 or 1; m is an integer from 0 to 10 inclusive; p = 1 or 2; r = 0 or 1; w = 0 or 1; with the proviso that n is only 1 when X and/or Y form an additional carbon-carbon bond, and the sum of r and w is 0 or 1;; L is a linker/spacer group covalently bonded to, and replaces one hydrogen atom of one of the carbon atoms to which it is joined, said linker/spacer group being represented by the formula wherein: s is an integer of 0 or 1; t is an integer of 0 to 20 inclusive; R¹ is an electrophilic or nucleophilic moiety which allows for covalent attachment to an antibody or fragment thereof, or a synthetic linker which can be attached to an antibody or fragment thereof, or precursor thereof; and Cyc represents a cyclic aliphatic moiety, aromatic moiety, aliphatic heterocyclic moiety, or aromatic heterocyclic moiety, each of said moieties optionally substituted with one or more groups which do not interfere with binding to an antibody or antibody fragment; with the proviso that when s, t, m, r and n are 0, then R¹ other than carboxyl; or a pharmaceutically acceptable salt thereof; covalently attached to an antibody or antibody fragment.
Claim 104
Dependent Claim
18 words
A conjugate of Claim 98 wherein the antibody or antibody fragment is a monoclonal antibody or fragment thereof.
Claim 105
Dependent Claim
20 words
A conjugate of Claim 99 wherein the antibody or antibody fragment is CC-49, CC-49 F(ab′)₂, CC-83, CC-83 F(ab′)₂ or B72.3.
Claim 106
Dependent Claim
19 words
A conjugate of any one of Claims 98 through 100 wherein the compound is as defined in Claim 6.
Claim 107
Dependent Claim
19 words
A conjugate of any one of Claims 98 through 100 wherein the compound is as defined in Claim 8.
Claim 108
Dependent Claim
19 words
A conjugate of any one of Claims 98 through 100 wherein the compound is as defined in Claim 9.
Claim 109
Dependent Claim
19 words
A conjugate of any one of Claims 98 through 100 wherein the compound is as defined in Claim 14.
Claim 110
Dependent Claim
19 words
A conjugate of any one of Claims 98 through 100 wherein the compound is as defined in Claim 17.
Claim 111
Dependent Claim
19 words
A conjugate of any one of Claims 98 through 100 wherein the compound is as defined in Claim 19.
Claim 112
Dependent Claim
19 words
A conjugate of any one of Claims 98 through 100 wherein the compound is as defined in Claim 20.
Claim 113
Dependent Claim
19 words
A conjugate of any one of Claims 98 through 100 wherein the compound is as defined in Claim 32.
Claim 114
Dependent Claim
21 words
A pharmaceutical formulation comprising a conjugate as claimed in any one of Claims 77 through 97 with a pharmaceutically acceptable carrier.
Claim 115
Dependent Claim
29 words
A method for the diagnosis and/or treatment of a disease state in a mammal which comprises administering to said mammal an effective amount of the formulation of Claim 109.
Claim 116
Dependent Claim
11 words
A method of Claim 110 wherein the disease state is cancer.
References Cited (Backward Citations)
WO1984003698A1
Cited
US4678667A
Cited
EP0232751A1
Cited
EP0238196A1
Cited
EP0255471A1
Cited
EP0292689A2
Cited
EP0296522A2
Cited
WO1989001475A1
Cited
USPTO Annuity & Maintenance Windows
Maintenance schedule is calculated for granted US utility patents.